Publication | Closed Access

Incidence of acute exacerbation of idiopathic pulmonary fibrosis in patients receiving antifibrotic agents: Real-world experience

Acute Lung InjuryAntifibrotic TherapyFibrosisInflammatory Lung DiseaseReal-world ExperienceLung InflammationIdiopathic Pulmonary FibrosisClinical EpidemiologyPulmonary FibrosisAcute ExacerbationPulmonary MedicineMedicinePulmonary Disease